These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8834870)

  • 1. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids.
    Petschow BW; Batema RP; Ford LL
    Antimicrob Agents Chemother; 1996 Feb; 40(2):302-6. PubMed ID: 8834870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori.
    Sun CQ; O'Connor CJ; Roberton AM
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):9-17. PubMed ID: 12727360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal effects of fatty acids and monoglycerides on Helicobacter pylori.
    Bergsson G; Steingrímsson O; Thormar H
    Int J Antimicrob Agents; 2002 Oct; 20(4):258-62. PubMed ID: 12385681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of medium-chain monoglycerides on intestinal colonisation by Vibrio cholerae or enterotoxigenic Escherichia coli.
    Petschow BW; Batema RP; Talbott RD; Ford LL
    J Med Microbiol; 1998 May; 47(5):383-9. PubMed ID: 9879938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial study of the medium chain fatty acids and their 1-monoglycerides: individual effects and synergistic relationships.
    Batovska DI; Todorova IT; Tsvetkova IV; Najdenski HM
    Pol J Microbiol; 2009; 58(1):43-7. PubMed ID: 19469285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro killing of Candida albicans by fatty acids and monoglycerides.
    Bergsson G; Arnfinnsson J; Steingrímsson O ; Thormar H
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3209-12. PubMed ID: 11600381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycerol monolaurate antibacterial activity in broth and biofilm cultures.
    Schlievert PM; Peterson ML
    PLoS One; 2012; 7(7):e40350. PubMed ID: 22808139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia.
    Al-Qurashi AR; El-Morsy F; Al-Quorain AA
    Int J Antimicrob Agents; 2001 Mar; 17(3):233-6. PubMed ID: 11282271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
    Coudron PE; Stratton CW
    J Antimicrob Chemother; 1998 Nov; 42(5):657-60. PubMed ID: 9848452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
    Boyanova L; Stancheva I; Spassova Z; Katzarov N; Mitov I; Koumanova R
    J Med Microbiol; 2000 May; 49(5):415-418. PubMed ID: 10798553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The products from lipase-catalysed hydrolysis of bovine milkfat kill Helicobacter pylori in vitro.
    Sun CQ; O'Connor CJ; MacGibbon AK; Roberton AM
    FEMS Immunol Med Microbiol; 2007 Mar; 49(2):235-42. PubMed ID: 17328757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori.
    Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y
    Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
    Phillips K; Munster DJ; Allardyce RA; Bagshaw PF
    J Clin Pathol; 1993 Apr; 46(4):372-3. PubMed ID: 8496397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of neem (Azadirachta indica) oil extract against Helicobacter pylori.
    Blum FC; Singh J; Merrell DS
    J Ethnopharmacol; 2019 Mar; 232():236-243. PubMed ID: 30578933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
    Ling TK; Cheng AF; Sung JJ; Yiu PY; Chung SS
    Helicobacter; 1996 Mar; 1(1):57-61. PubMed ID: 9398914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fatty acids and their monoesters on the metabolic activity of dental plaque.
    Hayes ML
    J Dent Res; 1984 Jan; 63(1):2-5. PubMed ID: 6582076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms.
    Huang CB; Alimova Y; Myers TM; Ebersole JL
    Arch Oral Biol; 2011 Jul; 56(7):650-4. PubMed ID: 21333271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
    Boyanova L; Evstatiev I; Gergova G; Yaneva P; Mitov I
    Int J Antimicrob Agents; 2015 Dec; 46(6):703-6. PubMed ID: 26453146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
    Pastukh N; Peretz A; Brodsky D; Isakovich N; Azrad M; On A
    J Glob Antimicrob Resist; 2018 Mar; 12():175-178. PubMed ID: 29033302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria.
    Ani AE; Malu AO; Onah JA; Queiroz DM; Kirschner G; Rocha GA
    Trans R Soc Trop Med Hyg; 1999; 93(6):659-61. PubMed ID: 10717760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.